Bill Snyder Archive — Page 53 of 118

October 3, 2019

Team discovers one more piece to the autism puzzle

Vanderbilt investigators have linked genetic mutations in a single receptor to epilepsy, autism and intellectual disability.

By Bill Snyder
Adriana Hung, MD, MPH, talks with patient Sylvester Norman, who is participating in the VA Department’s Million Veteran Program.
September 25, 2019

Study shines light on architecture of kidney disease

A study of 280,000 U.S. veterans, including 56,000 African Americans, has identified in greater detail than ever before the genetic architecture of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues.

By Bill Snyder
September 24, 2019

Nobel laureate Südhof set for Oct. 3 Discovery Lecture

Nobel laureate Thomas Südhof, MD, whose studies of synaptic formation and transmission are advancing understanding of brain disorders including autism, Alzheimer’s disease and schizophrenia, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 3.

By Bill Snyder
array of test tubes with pipette dropping fluid into one
September 20, 2019

Guengerich, Sanders-Bush named ASPET fellows

Vanderbilt University’s F. Peter (Fred) Guengerich, PhD, and Elaine Sanders-Bush, PhD, are among 22 prominent scientists named this week to the inaugural class of fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET).

By Bill Snyder
From left, Jennifer Pietenpol, PhD, VUMC Executive Vice President for Research, Vanderbilt Prize in Biomedical Science recipient Christine Seidman, MD, Vanderbilt Prize Scholar Megan Rasmussen and Lawrence Marnett, PhD, Dean of Basic Sciences, School of Medicine.
September 19, 2019

Genetics key to treating heart muscle disorders: Vanderbilt Prize lecturer

Advances in genetics are leading to new ways to treat cardiomyopathies — devastating heart muscle disorders that lead to heart failure.

By Bill Snyder
September 13, 2019

Early effort to thwart chikungunya infection shows positive results

Phase 1 trial results in new approach to combat the chikungunya

By Bill Snyder